Medicenna Therapeutics Corp. (MDNAF) stock
MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2023, year ended Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)
Close on Oct 19, 2026
Medicenna Therapeutics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Medicenna Therapeutics
Medicenna Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?